5.91
+0.014(+0.24%)
Currency In USD
| Previous Close | 5.9 |
| Open | 5.84 |
| Day High | 6.15 |
| Day Low | 5.84 |
| 52-Week High | 11.57 |
| 52-Week Low | 3.81 |
| Volume | 2,745 |
| Average Volume | 11,724 |
| Market Cap | 58.91M |
| PE | 1.75 |
| EPS | 3.38 |
| Moving Average 50 Days | 5.81 |
| Moving Average 200 Days | 5.52 |
| Change | 0.01 |
If you invested $1000 in Serina Therapeutics Inc (SER) since IPO date, it would be worth $61.06 as of July 12, 2025 at a share price of $5.91. Whereas If you bought $1000 worth of Serina Therapeutics Inc (SER) shares 5 years ago, it would be worth $180.46 as of July 12, 2025 at a share price of $5.91.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Serina Therapeutics Makes Grant to New Employee Under Inducement Plan
GlobeNewswire Inc.
Jul 10, 2025 8:10 PM GMT
HUNTSVILLE, AL, July 10, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company advancing its lead IND candidate SER-252 for advanced Parkinson's disease, enabled by its proprietar
Serina Therapeutics Announces Date for 2025 Annual Stockholders Meeting
GlobeNewswire Inc.
Jul 01, 2025 8:15 PM GMT
HUNTSVILLE, July 01, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company, today announced that its Board of Directors has established November 7, 2025, as the date of its 2025 a
Serina Therapeutics to Present at FORCE Family Office Investor Webinar on June 26, 2025
GlobeNewswire Inc.
Jun 23, 2025 11:24 PM GMT
How Parkinson’s affects million – and why current treatments are not enoughContinuous dopaminergic stimulation (CDS): a next-gen approach to Parkinson’s careSerina’s drug candidate SER-252 is designed to deliver continuous symptom reliefJoin Serina C